Adam Luchey

Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial

Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety et al. · The Lancet Oncology · 2020 · 412 citations · Full text

Urology, Oncology, Genitourinary Cancer +2

Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin–Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial

Vikram M. Narayan, Stephen A. Boorjian, Mehrdad Alemozaffar et al. · The Journal of Urology · 2024 · 64 citations · Full text

Racial and economic disparities in the treatment of penile squamous cell carcinoma: Results from the National Cancer Database

Pranav Sharma, Kenan Ashouri, Kamran Zargar‐Shoshtari et al. · Urologic Oncology Seminars and Original Investigations · 2015 · 45 citations

Racial Disparities, National Cancer Database, Urology +12

Change in Management Based on Pathologic Second Opinion Among Bladder Cancer Patients Presenting to a Comprehensive Cancer Center: Implications for Clinical Practice

Adam Luchey, Neil J. Manimala, Shohreh Dickinson et al. · Urology · 2016 · 38 citations

Urology, Surgical Oncology, Genitourinary Cancer +8

Predictors of Postoperative Complications in Patients Who Undergo Radical Nephrectomy and IVC Thrombectomy: A Large Contemporary Tertiary Center Analysis

Kathy Lue, Christopher Russell, John Fisher et al. · Clinical Genitourinary Cancer · 2015 · 29 citations

Ivc Thrombectomy, Surgical Oncology, Urology +10